Review: Do patients with functional gastrointestinal disorders have an altered gut flora?
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The description of the de novo development of irritable bowel syndrome (IBS) following an episode of bacterial gastroenteritis (postinfectious IBS) illustrated the potential for a luminal factor (a bacterial pathogen) to cause this common gastrointestinal ailment. As a consequence of these and other observations as well as results of experiments involving animal models, the enteric flora and the immune response that it generates in the host have, somewhat surprisingly, come centre-stage in IBS research with their potential to induce the pathophysiological changes that are associated with IBS. While evidence for immune dysfunction both in the mucosa and systemically continues to accumulate, methodological limitations have hampered a full delineation of the nature of the microbiota in IBS. The latter is eagerly awaited and may yet provide a firm rationale for the use of certain probiotics and antibiotics in IBS, whose benefits have now been described with some consistency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475 · cited 1×
“Subsequent studies have provided further evidence of T-lymphocyte [Holmen et al. 2007; Ohman et al. 2005] and mast cell activation [Barbara et al. 2007, 2004; Cenac et al. 2007, Guilarte et al. 2007] in the mucosa in IBS; others have demonstrated an extension of inflammation into the myo-neural…”
ResultO’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Self-citationSpiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155 · cited 2×
“Others have demonstrated a persisting increase in rectal mucosal enteroendocrine cells, T-lymphocytes and gut permeability in patients with postdysenteric IBS [Dunlop et al. 2003; Spiller et al. 2000].”
BackgroundResultPostinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002 · cited 1×
“Molecular methods are now being applied to this complex issue and have, indeed, confirmed that IBS patients, regardless of sub-type, do exhibit a fecal flora that is clearly different from control subjects [Kassinen et al. 2007; Maukonen et al. 2006; Matto et al. 2005; Malinen et al. 2005].”
MethodActivation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833 · cited 1×
“However, among the group with ‘normal’ histology, immunohistology revealed increased intraepithelial lymphocytes as well as an increase in CD3þ and CD25þ cells in the lamina propria; all therefore showed evidence of immune activation [Chadwick et al. 2002].”
BackgroundMast Cell-Dependent Excitation of Visceral-Nociceptive Sensory Neurons in Irritable Bowel Syndrome
Barbara, G., Wang, B., Stanghellini, V., de Giorgio, R., Cremon, C., Di Nardo, G., Trevisani, M., Campi, B., Geppetti, P., Tonini, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.039 · Cited by 783 · cited 1×
“Subsequent studies have provided further evidence of T-lymphocyte [Holmen et al. 2007; Ohman et al. 2005] and mast cell activation [Barbara et al. 2007, 2004; Cenac et al. 2007, Guilarte et al. 2007] in the mucosa in IBS; others have demonstrated an extension of inflammation into the myo-neural…”
ResultEradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780 · cited 4×
“These striking results have been the target of much criticism on several grounds [Vanner, 2008b; Quigley, 2007; Cuoco et al. 2001; Jones et al. 2001; Mishkin et al. 2001; Riordan et al. 2001; Hasler, 2003].”
BackgroundResultInfluentialThe role of psychological and biological factors in postinfective gut dysfunction
Gwee, K.-A., Leong, Y.-L., Graham, C., McKendrick, M. W., Collins, S. M., Walters, S. J., Underwood, J. E., & Read, N. W. (1999) · Gut · doi:10.1136/gut.44.3.400 · Cited by 764
Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699 · cited 3×
“Molecular methods are now being applied to this complex issue and have, indeed, confirmed that IBS patients, regardless of sub-type, do exhibit a fecal flora that is clearly different from control subjects [Kassinen et al. 2007; Maukonen et al. 2006; Matto et al. 2005; Malinen et al. 2005].”
BackgroundMethod
Cited by
Brain-gut-microbe communication in health and disease
Grenham, S., Clarke, G., Cryan, J. F., & Dinan, T. G. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00094 · Cited by 952
“…in the field consider such a mechanism, www.frontiersin.org December 2011 | Volume 2 | Article 94 | 9 along with the assumption of competition with and exclusion of pathogens, to be overly simplistic and undermined by an incomplete knowledge of what constitutes a“normal”microbiome (Quigley, 2009).”
BackgroundInfluentialExercise Modifies the Gut Microbiota with Positive Health Effects
Monda, V., Villano, I., Messina, A., Valenzano, A., Esposito, T., Moscatelli, F., Viggiano, A., Cibelli, G., Chieffi, S., Monda, M., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3831972 · Cited by 654
Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives
Salonen, A., de Vos, W. M., & Palva, A. (2010) · Microbiology · doi:10.1099/mic.0.043257-0 · Cited by 264
“This review focuses on recent GI microbiota research in IBS patients, with a special emphasis on mining the subtype-specific findings obtained using culture-independent methods, as the initial culture-based studies had various limitations and have already been thoroughly reviewed in the existing literature (Lee & Tack…”
MethodDuPont, H. L. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12728 · Cited by 171
The effects and mechanism of action of methane on ileal motor function
Park, Y. M., Lee, Y. J., Hussain, Z., Lee, Y. H., & Park, H. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13077 · Cited by 27
Metadata
- Authors
- Quigley, E. M. M.
- Venue
- Therapeutic Advances in Gastroenterology
- Publisher
- SAGE Publications
- Published
- 2009-07
- Volume
- 2
- Issue
- 4_suppl
- Pages
- S23-S30
- ISSN
- 1756-283X (ISSN-L)
- 1756-2848
- OpenAlex
- W2037253806
- Cited by
- 17
- References
- 32
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review: Do patients with functional gastrointestinal disorders have an altered gut flora? https://app.cochat.ai/papers/10.1177/1756283x09335636
- The paper
- Quigley, E. M. M. (2009). Review: Do patients with functional gastrointestinal disorders have an altered gut flora? Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756283x09335636
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.